1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept : Results from the international TOCERRA and PANABA observational collaborative studies
(
- Contribution to journal › Article
- 2019
-
Mark
Imputing missing data of function and disease activity in rheumatoid arthritis registers : What is the best technique?
(
- Contribution to journal › Article
- 2017
-
Mark
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
(
- Contribution to journal › Article
- 2014
-
Mark
The impact of obesity on the development and progression of rheumatoid arthritis.
(
- Contribution to journal › Debate/Note/Editorial